Keith A. Cengel

10.9k total citations · 1 hit paper
193 papers, 8.0k citations indexed

About

Keith A. Cengel is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Keith A. Cengel has authored 193 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 148 papers in Pulmonary and Respiratory Medicine, 47 papers in Radiology, Nuclear Medicine and Imaging and 43 papers in Oncology. Recurrent topics in Keith A. Cengel's work include Photodynamic Therapy Research Studies (50 papers), Occupational and environmental lung diseases (35 papers) and Nanoplatforms for cancer theranostics (35 papers). Keith A. Cengel is often cited by papers focused on Photodynamic Therapy Research Studies (50 papers), Occupational and environmental lung diseases (35 papers) and Nanoplatforms for cancer theranostics (35 papers). Keith A. Cengel collaborates with scholars based in United States, China and France. Keith A. Cengel's co-authors include Stephen M. Hahn, Patrizia Agostinis, Jacques Piette, Mladen Korbelik, Brian C. Wilson, Thomas H. Foster, Kristian Berg, Asta Juzeniene, Dominika Nowis and Albert W. Girotti and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Keith A. Cengel

178 papers receiving 7.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Photodynamic therapy of cancer: An update

2011 4.3k citations Patrizia Agostinis, Kristian Berg et al. CA A Cancer Journal for Clinicians profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Keith A. Cengel United States	36	4.9k	4.2k	1.8k	1.4k	929	193	8.0k
Ron R. Allison United States	34	3.3k 0.7×	2.9k 0.7×	1.5k 0.8×	963 0.7×	413 0.4×	89	5.0k
Nancy L. Oleinick United States	52	5.3k 1.1×	4.3k 1.0×	2.3k 1.2×	3.4k 2.3×	648 0.7×	182	9.0k
Gooitzen M. van Dam Netherlands	48	2.2k 0.5×	3.1k 0.7×	1.1k 0.6×	1.5k 1.0×	1.5k 1.6×	169	8.8k
Mladen Korbelik Canada	42	9.2k 1.9×	9.3k 2.2×	3.9k 2.1×	2.3k 1.6×	670 0.7×	159	13.2k
Barbara W. Henderson United States	45	9.2k 1.9×	8.0k 1.9×	3.8k 2.1×	2.0k 1.4×	491 0.5×	90	11.7k
Sunil Krishnan United States	52	2.4k 0.5×	1.7k 0.4×	725 0.4×	2.1k 1.4×	3.3k 3.6×	154	8.8k
Qian Peng Norway	46	7.9k 1.6×	6.8k 1.6×	3.5k 1.9×	3.4k 2.4×	674 0.7×	199	12.9k
Muriel Barberi‐Heyob France	34	1.8k 0.4×	2.1k 0.5×	1.3k 0.7×	1.2k 0.8×	687 0.7×	109	4.4k
François Guillemin France	45	2.7k 0.6×	2.7k 0.6×	1.8k 1.0×	1.3k 0.9×	635 0.7×	205	6.3k
Charles J. Gomer United States	43	10.6k 2.2×	8.5k 2.0×	4.1k 2.2×	3.3k 2.3×	589 0.6×	91	14.2k

Countries citing papers authored by Keith A. Cengel

Since Specialization

Citations

This map shows the geographic impact of Keith A. Cengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith A. Cengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith A. Cengel more than expected).

Fields of papers citing papers by Keith A. Cengel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith A. Cengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith A. Cengel. The network helps show where Keith A. Cengel may publish in the future.

Co-authorship network of co-authors of Keith A. Cengel

This figure shows the co-authorship network connecting the top 25 collaborators of Keith A. Cengel. A scholar is included among the top collaborators of Keith A. Cengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith A. Cengel. Keith A. Cengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Huan, Lutian Yao, Leilei Zhong, et al.. (2025). Marrow adipogenic lineage precursors (MALPs) facilitate bone marrow recovery after chemotherapy. Bone. 195. 117446–117446.

Yegya‐Raman, Nikhil, et al.. (2025). Salvage thoracic reirradiation for recurrent non-small cell lung cancer: Clinical efficacy and the impact of consolidative immunotherapy. Radiotherapy and Oncology. 208. 110911–110911. 1 indexed citations

Cengel, Keith A., Michele M. Kim, Eric S. Diffenderfer, & Theresa M. Busch. (2024). FLASH Radiotherapy: What Can FLASH's Ultra High Dose Rate Offer to the Treatment of Patients With Sarcoma?. Seminars in Radiation Oncology. 34(2). 218–228. 6 indexed citations

Diffenderfer, Eric S., François Vander Stappen, Seyyedeh Azar Oliaei Motlagh, et al.. (2024). Commissioning, Quality Assurance, and First Canine Treatment with a Conformal Proton Flash Delivery System. International Journal of Radiation Oncology*Biology*Physics. 120(2). S139–S139.

Davis, Richard W., Astero Klampatsa, Gwendolyn M. Cramer, et al.. (2023). Surgical Inflammation Alters Immune Response to Intraoperative Photodynamic Therapy. Cancer Research Communications. 3(9). 1810–1822. 1 indexed citations

Lee, Sang Ho, Bolin Li, Abigail Doucette, et al.. (2023). The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC. Radiotherapy and Oncology. 190. 110030–110030. 17 indexed citations

Yegya‐Raman, Nikhil, Siqi Zhang, Roger B. Cohen, et al.. (2023). Patterns of Failure in Metastatic NSCLC Treated With First Line Pembrolizumab and Use of Local Therapy in Patients With Oligoprogression. Clinical Lung Cancer. 25(1). 50–60.e6. 7 indexed citations

Lee, Sang Ho, Bolin Li, William P. Levin, et al.. (2023). Patterns of Failure, Low-Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors. International Journal of Radiation Oncology*Biology*Physics. 118(5). 1435–1444. 9 indexed citations

Luna, José Marcio, Andrew R. Barsky, Russell T. Shinohara, et al.. (2022). Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation. Cancers. 14(3). 700–700. 7 indexed citations

10.

Pietrofesa, Ralph A., Evguenia Arguiri, Constantinos Koumenis, et al.. (2021). Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer. The Journal of Alternative and Complementary Medicine. 27(10). 824–831. 6 indexed citations

11.

Miller, Joann M., Gwendolyn M. Cramer, Min Yuan, et al.. (2021). Adjuvant Photodynamic Therapy, Mediated via Topical Versus Systemic Administration of 5‐Aminolevulinic Acid for Control of Murine Mammary Tumor after Surgical Resection^†. Photochemistry and Photobiology. 98(1). 117–126. 3 indexed citations

12.

Frick, Melissa A., Steven J. Feigenberg, Samuel Swisher‐McClure, et al.. (2020). Circulating Tumor Cells Are Associated with Recurrent Disease in Patients with Early-Stage Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiotherapy. Clinical Cancer Research. 26(10). 2372–2380. 44 indexed citations

13.

Klampatsa, Astero, Shaun O’Brien, Jeffrey C. Thompson, et al.. (2019). Phenotypic and functional analysis of malignant mesothelioma tumor-infiltrating lymphocytes. OncoImmunology. 8(9). e1638211–e1638211. 34 indexed citations

14.

Schonewolf, Caitlin A., Abigail Doucette, Sunil Singhal, et al.. (2018). Five-year Long-term Outcomes of Stereotactic Body Radiation Therapy for Operable Versus Medically Inoperable Stage I Non–small-cell Lung Cancer: Analysis by Operability, Fractionation Regimen, Tumor Size, and Tumor Location. Clinical Lung Cancer. 20(1). e63–e71. 30 indexed citations

15.

Rice, Stephanie R., Leslie A. Lange, Theresa M. Busch, et al.. (2018). A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma. Photochemistry and Photobiology. 95(1). 411–418. 20 indexed citations

16.

Gallagher‐Colombo, Shannon M., Joann M. Miller, Keith A. Cengel, et al.. (2015). Erlotinib Pretreatment Improves Photodynamic Therapy of Non–Small Cell Lung Carcinoma Xenografts via Multiple Mechanisms. Cancer Research. 75(15). 3118–3126. 38 indexed citations

17.

Kennedy, Ann R. & Keith A. Cengel. (2012). Acute Radiation Effects Resulting from Exposure to Solar Particle Event-Like Radiation. cosp. 39. 907. 1 indexed citations

18.

Agostinis, Patrizia, Kristian Berg, Keith A. Cengel, et al.. (2011). Photodynamic therapy of cancer: An update. CA A Cancer Journal for Clinicians. 61(4). 250–281. 4317 indexed citations breakdown →

19.

Dowling, Melissa L., et al.. (2010). Effects of anti-EGFR antibody cetuximab on androgen-independent prostate cancer cells.. PubMed. 30(6). 1905–10. 13 indexed citations

20.

Prevo, Remko, Éric Deutsch, Oliver Sampson, et al.. (2008). Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity. Cancer Research. 68(14). 5915–5923. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact